Cargando…
Ruxolitinib in conjunction with the HLH-94 protocol for Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in the intensive care unit: A case report
RATIONALE: The HLH-94 protocol is a standard induction treatment for hemophagocytic lymphohistiocytosis. However, about 30% of patients may not respond. Ruxolitinib has been clinically proven to be an effective treatment for hemophagocytic lymphohistiocytosis (HLH). PATIENT CONCERNS: A previously he...
Autores principales: | Huang, Zoufang, Xie, Jiangbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982154/ https://www.ncbi.nlm.nih.gov/pubmed/33726009 http://dx.doi.org/10.1097/MD.0000000000025188 |
Ejemplares similares
-
Successful Treatment of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis with HLH-94 Protocol
por: Lee, Jin-Seok, et al.
Publicado: (2005) -
Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein–Barr virus (EBV)-related hemophagocytic lymphohistiocytosis
por: Zhao, Yunze, et al.
Publicado: (2020) -
Not another case of mono: Epstein-Barr virus (EBV) associate hemophagocytic lymphohistiocytosis (HLH)
por: Boyarsky, Marina, et al.
Publicado: (2013) -
Familial hemophagocytic lymphohistiocytosis in a neonate: Case report and literature review
por: Yang, Yue, et al.
Publicado: (2021) -
Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
por: Marsh, Rebecca A.
Publicado: (2018)